Bunchy Carter
I'll Take The Money Over The Honey
First Vaccinations Begin in Africa for COVID-19 Trial
Africa’s first participation in a COVID-19 vaccine trial has begun as volunteers received injections, while officials say the continent of 1.3 billion people cannot be left behind.
By Associated Press, Wire Service Content June 24, 2020, at 11:30 a.m.
The Spread of Coronavirus]
Cameroon, Uganda, Tanzania, Kenya and South Africa all have highly developed clinical trial capabilities, said Salim Abdool Karim, chair of South Africa's ministerial advisory committee for COVID-19.
Many other sub-Saharan African countries also have clinical trial capacity, said Daniel Bausch, director of the UK Public Health Rapid Support Team.
“We're not only needing but capable of participating" as the world races for a vaccine, South Africa's Health Minister Zweli Mkhize said.
African leaders have been outspoken about the continent being elbowed out in the intense global competition for medical supplies in this pandemic, as well as what the World Health Organization's Africa chief, Matshidiso Moeti, called the “distortion of the global market for key items.”
WHO chief Tedros Adhanom Ghebreyesus urged that the initial supply of any COVID-19 vaccine be deployed where it’s most needed, rather than based on the “ability to pay.”
Tedros also announced that as of this week, all 54 of Africa's countries now have the lab capacity to test for the coronavirus.
In February, just two African nations could test for the virus. The continent's first virus case was reported on Feb. 14.
___
Follow AP pandemic coverage at Virus Outbreak and Understanding the Outbreak
Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Africa’s first participation in a COVID-19 vaccine trial has begun as volunteers received injections, while officials say the continent of 1.3 billion people cannot be left behind.
By Associated Press, Wire Service Content June 24, 2020, at 11:30 a.m.
The Spread of Coronavirus]
Cameroon, Uganda, Tanzania, Kenya and South Africa all have highly developed clinical trial capabilities, said Salim Abdool Karim, chair of South Africa's ministerial advisory committee for COVID-19.
Many other sub-Saharan African countries also have clinical trial capacity, said Daniel Bausch, director of the UK Public Health Rapid Support Team.
“We're not only needing but capable of participating" as the world races for a vaccine, South Africa's Health Minister Zweli Mkhize said.
African leaders have been outspoken about the continent being elbowed out in the intense global competition for medical supplies in this pandemic, as well as what the World Health Organization's Africa chief, Matshidiso Moeti, called the “distortion of the global market for key items.”
WHO chief Tedros Adhanom Ghebreyesus urged that the initial supply of any COVID-19 vaccine be deployed where it’s most needed, rather than based on the “ability to pay.”
Tedros also announced that as of this week, all 54 of Africa's countries now have the lab capacity to test for the coronavirus.
In February, just two African nations could test for the virus. The continent's first virus case was reported on Feb. 14.
___
Follow AP pandemic coverage at Virus Outbreak and Understanding the Outbreak
Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
jesus christ...
